Munich, Germany, – Definiens, the global leader of image and data analysis solutions for quantitative digital pathology, today announced it has appointed an Advisory Board comprising renowned industry experts and visionaries in digital pathology. As part of its market expansion strategy, Definiens established the new Board to provide independent advice on trends and opportunities in […]
Genalyte Announces CE Mark for Maverick TM Detection System and Signs On First European Distributors
SAN DIEGO, CA –– Genalyte, Inc. today announced its MaverickTM Detection System that simultaneously analyzes multiple antibodies and other proteins from a single small sample is now CE marked in Europe for research use. The company also reported its first European distribution agreements for the Maverick Detection System, signing on specialty distributors Mokascience in France, […]
WALTHAM, Mass. –– ViaCord, PerkinElmer’s family cord blood and tissue preservation business, announced today the release of its 250th umbilical cord blood stem cell unit for use in medical treatments and clinical trials. For nearly 20 years, ViaCord has released life-saving stem cells for disease therapies using a proven method of processing and cryopreserving cord […]
Mansfield, MA, – PrimeraDx, Inc., a molecular diagnostics company, today announced it has formed a non-exclusive diagnostics co-development agreement with Quest Diagnostics (NYSE: DGX), the world’s leading diagnostics information services company. The intent of the collaboration is to co-develop and commercialize molecular diagnostic products and services with a focus on supporting clinical development of targeted […]
The first multi-gene DNA sequencing test that can help predict cancer patients’ responses to treatment has been launched in the National Health Service (NHS), thanks to a partnership between scientists at the University of Oxford and Oxford University Hospitals NHS Trust. The test uses the latest DNA sequencing techniques to detect mutations across 46 genes […]
FREMONT, Calif.– Thermo Fisher Scientific Inc., the world leader in serving science, today the launch of the new Thermo Scientific LabLink xL Cloud Communicator to provide fully automated, real-time data transfer of quality control (QC) data from the Data Innovations Instrument Manager to LabLink xL software. The Cloud Communicator tool eliminates the requirement for additional […]
BEDFORD, Mass., — Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that it has successfully completed its sale of the LIFECODES business unit to Immucor, Inc. Hologic has received $85 […]
SAN DIEGO, — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that Sequenom Center for Molecular Medicine (SCMM) has launched an advanced new cystic fibrosis carrier screen test branded under the name Heredi-T™. The laboratory-developed test (LDT) is now available as a testing service to ordering physicians. The […]
Phoenix, AZ, USA — SciGene announced today at the Annual College of Medical Genetics Meeting (ACMG) in Phoenix, AZ the launch of CytoZyme™ Stabilized Pepsin, an advanced formulation of pepsin for pre-treating tissue samples in nucleic acid probe based cytogenetic assays including FISH. CytoZyme is a ready-to-use solution of purified pepsin that can be stored […]
Irvine, CA, USA — SciGene (Sunnyvale, CA) and BioDot, Inc. (Irvine, CA) today announced at the American College of Medical Genetics Meeting (ACMG) in Phoenix, AZ an agreement whereby BioDot would have exclusive rights to market and sell SciGene’s Little Dipper® Processor for FISH (fluorescence in situ hybridization) to cytogenetic labs worldwide. The SciGene instrument […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
